The Auditorium : OFFICIAL WELCOME & LARGE CLINICAL TRIALS

10:30

OPENING SPEECHES

10:45

A RANDOMIZED TRIAL OF UNRUPTURED BRAIN AVMS (ARUBA): FINAL OUTCOME RESULTS BY TREATMENT MODALITY
C. Stapf, Canada

10:55

CLOT LYSIS: EVALUATING ACCELERATED RESOLUTION OF INTRAVENTRICULAR HEMORRHAGE (CLEAR III) 365-DAY RESULTS
K. Lane, USA

11:25

ULTRASOUND ENHANCED THROMBOLYSIS FOR ISCHEMIC STROKE: RESULTS OF A MULTI-NATIONAL PHASE III TRIAL (CLOTBUSTER)
Andrei V. Alexandrov, USA

11:35

ENCHANTED MAIN RESULTS - TRIAL OF LOW-DOSE VERSUS STANDARD-DOSE INTRAVENOUS TISSUE PLASMINOGEN ACTIVATOR IN 3310 PATIENTS WITH ACUTE ISCHEMIC STROKE
Craig Anderson, Australia

11:40

EFFICACY OF LOW-DOSE VS STANDARD-DOSE RTPA BETWEEN ASIAN AND NON-ASIAN WITH PARTICULAR EMPHASIS ON STROKE SUBTYPE AND RISK OF INTRACEREBRAL HEMORRHAGE
John Chalmers, Australia

11:45

BENEFITS AND RISKS OF LOW- VERSUS STANDARD-DOSE ALTEPLASE IN PATIENTS ON PRIOR ANTIPLATELET THERAPY: THE ENCHANTED TRIAL
T. Robinson, United Kingdom

11:55

TICAGRELOR VS. ASPIRIN IN ACUTE STROKE OR TRANSIENT ISCHEMIC ATTACK: PRIMARY RESULTS OF THE SOCRATES RANDOMIZED TRIAL
S.C. Johnston, USA

The Auditorium : PRESIDENTS' SYMPOSIUM: AWARDS AND TRIALS

14:15

AWARDS

14:35

FACTOR XA INHIBITORS VERSUS VITAMIN K ANTAGONISTS FOR PREVENTING CEREBRAL OR SYSTEMIC EMBOLISM IN PATIENTS WITH ATRIAL FIBRILLATION: RESULTS FROM AN UPDATED COCHRANE SYSTEMATIC REVIEW
E. Borge, Norway

15:05

THE VERTEBRAL ARTERY ISCHAEMIA STENTING TRIAL (VIST) - FIRST RESULTS ON BEHALF OF THE VIST INVESTIGATORS
H. Markus, United Kingdom

15:25

EFFECTS OF ALTEPLASE WITHIN 6 HOURS OF ISCHAEMIC STROKE ON SURVIVAL UP TO 3 YEARS: RESULTS FROM THE THIRD INTERNATIONAL STROKE TRIAL
E. Berge, Norway

15:35

PLATELET TRANSFUSION IN CEREBRAL HAEMORRHAGE (PATCH): A RANDOMISED CONTROLLED CLINICAL TRIAL
Yvo Roos, Netherlands